Impel Pharmaceuticals (IMPL) Q4 2022 Earnings

24MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.31
-1.2
-1.08
-0.97

Details

Expected EPS
-1.11
Actual EPS
-0.97
Surprise EPS
0.14
Surprise Percent
+12.61%

Description

Impel Pharmaceuticals (IMPL) has reported earnings of -0.97 per share for Q4 2022.

0 Comments

Share your thoughts